Respiratory syncytial virus infections – recent developments providing promising new tools for disease prevention-Reference-Cited by-同舟云学术

Respiratory syncytial virus infections – recent developments providing promising new tools for disease prevention

Published:2023-12-07 Issue:49 Volume:28 Page:
ISSN:1560-7917
Container-title:Eurosurveillance
language:en
Short-container-title:

Author:

Broberg Eeva K¹^ORCID,Nohynek Hanna²^ORCID

Affiliation:

1. European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden

2. Finnish institute for health and welfare, Helsinki, Finland

Publisher

European Centre for Disease Control and Prevention (ECDC)

Subject

Virology,Public Health, Environmental and Occupational Health,Epidemiology

Reference20 articles.

1. European Medicines Agency (EMA). First RSV vaccine to protect infants up to 6 months of age and older adults: EMA; 21 Jul 2023. Available from: https://www.ema.europa.eu/en/news/first-rsv-vaccine-protect-infants-6-months-age-and-older-adults

2. European Medicines Agency (EMA). Beyfortus (nirsevimab) - An overview of Beyfortus and why it is authorised in the EU. Amsterdam: EMA; 2023. Available from: https://www.ema.europa.eu/en/documents/overview/beyfortus-epar-medicine-overview_en.pdf

3. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis.;Li;Lancet,2022

4. The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study.;Wildenbeest;Lancet Respir Med,2023

5. Age-Specific Estimates of Respiratory Syncytial Virus-Associated Hospitalizations in 6 European Countries: A Time Series Analysis.;Johannesen;J Infect Dis,2022

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain;Influenza and Other Respiratory Viruses;2024-05

2. RSV immunisation in infants: weighing the options;The Lancet Regional Health - Europe;2024-03

3. Uptake of intra‐muscular vitamin K administration after birth: A national cohort study;Acta Paediatrica;2024-02-22

4. Respiratory Syncytial Virus (RSV) and Intention to Recommend RSV Vaccination: A Cross-Sectional Survey of Cardiologists and Cardiac Nurses in Southern Italy;Infectious Disease Reports;2024-02-15

5. Impact of nirsevimab prophylaxis on paediatric respiratory syncytial virus (RSV)-related hospitalisations during the initial 2023/24 season in Luxembourg;Eurosurveillance;2024-01-25